Testosteronsubstitutionsbehandling af hypogonadisme hos mænd med prostatacancer

TY - JOUR

T1 - Testosteronsubstitutionsbehandling af hypogonadisme hos mænd med prostatacancer

AU - Jensen, Christian F S

AU - Fode, Mikkel

AU - Østergren, Peter

AU - Sønksen, Jens

PY - 2017

Y1 - 2017

N2 - Hypogonadism and prostate cancer (PCa) often coincide with increasing age. Recent reviews have found no evidence to suggest an increased risk of developing PCa with testosterone replacement therapy (TRT). The same lack of PCa risk is found in studies looking at men receiving TRT after radical prostatectomy for PCa. Reports on TRT in men on active surveillance are very few. In summary, current evidence does not support an association between TRT and an increased risk of PCa. Nevertheless, sufficiently powered trials with longer follow-up are warranted before making final conclusions.

AB - Hypogonadism and prostate cancer (PCa) often coincide with increasing age. Recent reviews have found no evidence to suggest an increased risk of developing PCa with testosterone replacement therapy (TRT). The same lack of PCa risk is found in studies looking at men receiving TRT after radical prostatectomy for PCa. Reports on TRT in men on active surveillance are very few. In summary, current evidence does not support an association between TRT and an increased risk of PCa. Nevertheless, sufficiently powered trials with longer follow-up are warranted before making final conclusions.

M3 - Tidsskriftartikel

C2 - 28263152

SN - 0041-5782

VL - 179

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 9

M1 - V10160711

ER -